Longley, Rhea J.
Salman, Ahmed M.
Cottingham, Matthew G.
Ewer, Katie
Janse, Chris J.
Khan, Shahid M.
Spencer, Alexandra J.
Hill, Adrian V. S.
Article History
Received: 11 March 2015
Accepted: 1 June 2015
First Online: 3 July 2015
Competing interests
: AVSH is a named investigator on US 12/595 574 and UK PCT/GB2008/01262 novel adenovirus patent applications covering malaria vectored vaccines and immunization regimens; RJL, AMS, CJJ, SMK, AJS and AVSH are named investigators on filed patent (1318084.9) for novel malaria antigens. This work has been funded by a grant from the Wellcome Trust (095540/Z/11/Z) with additional funding by the Rhodes Trust and a Nuffield Department of Medicine Studentship to support RJL and EVIMalR studentship to support AMS. AVSH is a Jenner Institute Investigator; AJS is a James Martin Fellow. CJJ was supported by a grant of the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 242095.